waf1/cip1 is a potent inhibitor of cell cycle progression and can inhibit the growth of both normal cells and cells transformed by a number of oncogenes. However, the ability of p21 waf1/cip1 to inhibit the growth of cells that overexpress the transcriptional transactivator E2F1 is controversial: it has been reported both that E2F1 can and cannot overcome the block in the cell cycle induced by p21 waf1/cip1 . To avoid the complications that arise when such experiments are done with permanent cell lines, we tested the eects of overexpressing p21
Introduction
Progression of eukaryotic cells through the cell cycle is regulated by external stimuli and internal checkpoints. An important step in the cell cycle is the transition from G 1 into S phase. This transition is primarily controlled by the G 1 cyclins and their partners, cyclindependent kinases (cdks) (for review see Sherr, 1994) . A major phosphorylation target for the cyclin-cdk complex is the tumor suppressor pRb and the related family members, p130 and p107 (reviewed by Weinberg, 1995) . When pRb is hyperphosphorylated, the transcription factors that are bound to it are released. E2F is the best characterized of the Rb associated transcription factors. The active form of the E2F transcription factors are heterodimers that contain an E2F subunit and a DP subunit. Both E2F and DP are gene families; ®ve E2F family members and three DP family members have been cloned. When E2F is released from pRb, the transcription of S phase genes is increased. This is a key element of the progression to S phase (reviewed in Farnham et al., 1993; Hollingsworth et al., 1993 ; see also La Thangue, 1994; Nevins, 1994; DeGregori et al., 1995a) . E2F was ®rst identi®ed by its ability to bind to sequences in the adenovirus E2 promoter (Kovesdi et al., 1986) . Many cellular genes contain E2F binding sites and the transcription of such genes is regulated by E2F (for reviews see La Thangue, 1994; Nevins, 1994) . The ®rst member of the E2F family to be cloned, E2F1, was isolated because it can associated directly with pRb (Chellappan et al., 1991; Helin et al., 1992; Kaelin et al., 1992; Shan et al., 1992) . pRb suppresses transcriptional activation mediated by E2F1 through a direct interaction with E2F1; the transactivating domain of E2F1 and its pRb binding domain overlap (Flemington et al., 1993; and overexpression of pRb abrogates the ability of E2F1 to stimulate transcription . The inhibitory eect of pRb on E2F1 can be overcome by an inactivating mutation in pRb, by phosphorylation of pRb Flemington et al., 1993; Goodrich and Lee, 1993; Hiebert, 1993; Dynlacht et al., 1994) or by pRb interactions with viral oncoproteins (La Thangue, 1994; Nevins, 1994) . The expression of E2F1 is cell cycle dependent, the highest levels are seen at the G 1 / S boundary (Shan et al., 1992) . E2F1 can induce entry of quiescent cells into S phase and has been shown to be both an oncogene (Johnson et al., 1994) and a tumor suppressor (Field et al., 1996; Ymasaki et al., 1996) . Overexpression of E2F1 transforms a rat embryo ®broblast cell line (Singh et al., 1994) and causes rat ®broblasts to enter S phase and induces apoptosis (Qin et al., 1994; DeGregori et al., 1995a; Kowalik et al., 1995) .
The kinase activity of the cyclin-cdk complexes is regulated by cdk inhibitors (CKIs) that bind both to cyclin and cdk in the complex and inhibit the kinase activity of the holoenzyme (for review see Sherr and Roberts, 1995; Morgan, 1996) . Two families of inhibitors play important roles at the G 1 /S transition. The INK4 family members (p15, p16, p18 and p19) speci®cally inhibit cdk4 and cdk6. The other family of CKIs include p21 waf1 , p27 kip1 and p57 kip2 . They bind to cyclins and inhibit a greater variety of cyclin/cdk complexes. While the roles of the CKIs are complex, some aspects of their action(s) are clear. For example, one eect of the overexpression of p21 waf1/cip1 or p27 kip1 is to inhibit the phosphorylation of pRb. This, in turn, prevents the release of E2F from a complex with (hypophosphorylated) pRb and interferes with the entry of the cell into S phase (El-Deiry et al., 1993; Xiong et al., 1993; Peter and Herskowitz, 1994; Toyoshima and Hunter, 1994; Zhang et al., 1994; Harper et al., 1995) .
It has been reported that overexpression of E2F1 can overcome a G 1 block caused by p21 waf1/cip1 inhibition of cyclin/cdk activity (DeGregori et al., 1995b; Dimri et al., 1996) . This supports the idea that one of the eects of the G 1 cyclins-cdks is to release active E2F which then activates genes involved in S phase transition. However, it has also been reported that overexpression of p21 waf1/cip1 or p27 kip1 blocks the cell cycle in cells that overexpress E2F1 (Mann and Jones, 1996) .
We developed replication competent retroviral vectors that express high levels of human E2F1 protein in chicken embryo ®broblasts (CEF). Vectors are available with dierent envelope speci®cities so that the same cell can be infected with viruses expressing two dierent proteins. We have previously shown that overexpression of p21 waf1/cip1 (which will be referred to as p21) can arrest the growth of primary CEF transformed by a variety of oncogenes, both nuclear and cytoplasmic (Givol et al., 1995) . This system has the advantage that we are using primary cells, and that we can control the level of expression. Since overexpression of p21 leads to growth arrest at G 1 and since E2F1 has been reported both to be able and to be unable to overcome this arrest, we wished to test the eects of p21 in CEF that overexpress E2F1. In this report we show that CEF overexpressing human E2F1 are morphologically transformed and high levels of human p21 can arrest the growth of these cells. We also found that high levels of expression of human E2F1 causes apoptosis in CEF and that this eect can be blocked by high levels of human Bcl-2. This may have implications as to whether E2F1 functions as an oncogene or a tumor suppressor, which may be related to whether its expression does or does not lead to apoptosis.
Results

Description of avian retroviral vectors
The replication competent retroviral vector RCASBP is a derivative of RCAS (Hughes et al., 1987) . RCASBP contains the pol gene from the Bryan high titer strain of Rous Sarcoma Virus (RSV) and grows to a higher titer than the parental RCAS (Petropoulos and Hughes, 1991) . In both vectors the expression of the inserted genes is under the control of the viral LTR promoter; inserted genes are expressed at higher levels in CEF infected with RCASBP than with RCAS. We have developed RCAS and RCASBP vectors that express E2F1 (Figure 1 ). The human E2F1 cDNA (Kaelin et al., 1992) was inserted into the RCAS(A) and RCASBP(A) retroviral vectors (as described in Materials and methods) to generate RCAS(A)E2F1 (this vector will be referred to as E2F1) and RCASBP(A)E2F1 (which will be referred to as BP-E2F1). Both of the vectors have the same envelope speci®city (A); the dierence between them is that they induce the expression of dierent levels of both viral proteins and E2F1. As expected, CEF infected with the BP-E2F1 virus express higher levels of E2F1 than cells infected with the E2F1 virus (data not shown).
The RCASBP(B)p21 and RCASBP(B)bcl-2 vectors (Figure 1 ) have been described previously (Givol et al., 1994 (Givol et al., , 1995 . Because these viruses have a subgroup B envelope, they can be used to infect CEF that express E2F1 (subgroup A).
Expression of human E2F1 protein in CEF using retroviral vectors CEF were transfected with plasmids that encode the E2F1 and BP-E2F1 viruses. We used two dierent vectors to try to express dierent levels of E2F1 protein to ask whether, if the level of E2F1 was high enough, the p21 block could be overcome. At passage two after transfection, CEF infected with BP-E2F1 were morphologically transformed ( Figure 2a ). CEF infected with E2F1 were transformed at passage three post-transfection. This correlates with the dierence in growth rate of these two viruses, which is related to the dierence in the level of expression of viral proteins. Western blot analysis of E2F1 protein showed that the infected cells expressed an immunoreactive protein of the correct size ( Figure 3 , lanes 2 and 4).
The BP-E2F1 virus induces apoptosis in CEF
The initial eect of the BP-E2F1 virus on the morphology of CEF is more striking than that of the E2F1 virus (data not shown). Because so many cells undergo apoptosis and detach from the plate, the cells were passaged at high density (1:2) for a period of approximately 4 ± 6 days. The surviving cells could then be passaged normally (1:3 every 2 days). The cells that survived retained a transformed phenotype but showed little apoptosis. The levels of expression of retroviruses are modulated by the site of integration. We believe that the surviving cells are those that, by virtue of the integration of the provirus, express lower levels of E2F1. Western blot analysis of E2F1 protein in CEF infected with BP-E2F1 at passage 3 and passage 8 post-transfection showed that the average level of E2F1 protein was higher at passage 3 than at passage 8 ( Figure 3 , lanes 2 and 3). Furthermore, the level of E2F1 expression in cells infected with BP-E2F1 at passage 8 was comparable to the level of expression in CEF infected with E2F1 at passage 8 (Figure 3, lanes 2 and 4) . We believe that the lower levels of E2F1 protein seen in cells infected with BP-E2F1 at passage 8 is due to a selection for cells that express lower levels of E2F1 and are therefore less apoptotic. The ability of E2F1 to drive cells into S phase and induce apoptosis has been shown to depend on the levels of E2F1 in other systems Asano et al., 1996) .
Overexpression of p21 causes growth arrest of CEF morphologically transformed by E2F1
To determine whether p21 can inhibit the growth of CEF transformed by E2F1, CEF infected with either the BP-E2F1 or E2F1 virus (both of which were morphologically transformed, Figure 2b , upper panels), were infected with the p21 virus (Givol et al., 1995) . Both of the viruses expressing E2F1 are subgroup A, so that the p21 virus, which is subgroup B, was able to infect the E2F1 expressing cells. As shown in Figure 2b lower panels, overexpression of p21 causes growth Cultures infected with both the E2F1 and p21 viruses showed some growth after 10 days of arrest (indicated by the cultures reaching con¯uence). However, examination of these growing cells by Southern blot (data not shown) and Western blot analysis showed that they did not express p21 protein (Figure 5a , lane 4) but that they did express E2F1 protein (Figure 5b , lane 4). Similar results were observed for CEF infected with both the BP-E2F1 and p21 viruses (data not shown). This is similar to our previous observations in CEF that were infected with both the Src and p21 viruses or with the Myc and p21 viruses (Givol et al., 1995) . In those experiments, transformed cultures that were growth arrested by p21 also showed some growth after 10 days of arrest. The growing cells, however, did not overexpress human p21. Figure 6 , lower panels. There is a dramatic change in the cell cycle distribution. There is an approximately 20% increase in the number of cells in G 0 /G 1 and a fourfold decrease in the number of cells in S phase, indicating that, in this system, overexpression of p21 blocks the growth of cells transformed by E2F1. These results do not rule out the possibility that E2F1 can induce p21 growth arrested cells to enter S phase without completing the cell cycle, as reported previously (DeGregori et al., 1995b; Dimri et al., 1996) .
To address this question, vector infected and E2F1 infected CEF were each infected with equal amounts of the p21 virus. After 72 h, the cells were incubated with BrdU for 1 h to label newly synthesized DNA. Progression of these labeled cells was monitored for 24 h (see Materials and methods). The level of BrdU incorporation as well as the DNA content was analysed by bivariate¯ow cytometry. As seen in Figure 7 , no DNA synthesis is detected in cells expressing both E2F1 and p21 at 0 h and 2 h after BrdU labeling. We see no measurable DNA synthesis at other time points up to 24 h after BrdU labeling (data not shown). We have previously shown, by immunohistochemistry, that in CEF and CEF transformed by a variety of oncogenes, no DNA synthesis is detected in a cell that expresses p21 (Givol et al., 1995) .
Bcl-2 inhibits apoptosis in CEF that overexpress E2F1
We wished to test whether overexpression of Bcl-2 can inhibit the apoptosis induced by high levels of E2F1. We previously showed that overexpression of Bcl-2 can inhibit apoptosis in CEF that express c-Myc (Givol et al., 1994) . Although overexpression of Bcl-2 slows the growth of CEF, it does not induce cell cycle arrest in these cells. Following transfection with BP-E2F1 DNA, when all of the cells in the culture were transformed, we infected the culture with the Bcl-2 virus. The Bcl-2 virus completely inhibited the apoptosis caused by overexpression of E2F1 as seen 72 h postinfection (Figure 8 ).
Discussion
It is clear that the expression of high levels of p21 is sucient to block the growth of both normal CEF and CEF that express relatively high levels of several oncogenes (Givol et al., 1995) . These results suggest that oncogenic signals as well as mitogenic pathways converge at the cyclin/cdk complexes and aect the regulation of the cell cycle machinery. The connection between oncogenic signals and cell cycle checkpoints is important for our understanding of cell growth regulation and transformation. For example, the Ras/ Raf pathway can activate two opposing signals in primary rat Schwann cells; either cell cycle progression through cooperating oncogenes (Raf+SV40 LTAg or a dominant negative p53 mutant) or cell cycle arrest through elevation of p21 waf1/cip1 (Raf alone). The presence of a cooperating oncogene is required for shifting the signal from growth arrest towards proliferation (Lloyd et al., 1997) . The key regulatory step in the G 1 to S transition is thought to be the phosphorylation of pRb (by cyclin/cdks) and the release of E2F. In the original simple version of this model, p21, an inhibitor of cyclin/cdk kinase activity, is placed upstream of the pRb/E2F pathway and it was shown that p21 can inhibit E2F dependent transcriptional activity (Dimri et al., 1996; Michieli et al., 1996) and that E2F1 overexpression can overcome a p21 mediated growth arrest (DeGregori et al., 1995b; Dimri et al., 1996) . This model has been challenged by experiments which showed, in the pRb positive human osteosarcoma cell line (U2-OS), that overexpression of p21 can block the division of cells that overexpress E2F1 (Mann and Jones, 1996) .
Here we show that high levels of p21 can block the growth of CEF that express high levels of E2F1. Our results do not support the simple model which places E2F1 downstream of p21 since, in such a model, overexpression of E2F1 should be able to overcome a p21 block imposed on the pRb/E2F pathway. A particular advantage of the CEF system is that it is possible to test the interactions of proteins (like p21 and E2F1) in cells that are otherwise entirely normal. This eliminates complications that arise when the eects are measured in cell lines, which have additional, usually unde®ned, genetic changes that make them immortal in culture.
There are two obvious explanations for these results; either there is an additional role (or roles) for p21, which would place it either downstream of E2F1 or in parallel pathways that are also required for cell cycle progression, or alternatively we have not been able to express suciently high levels of E2F1 to overcome the p21 block. There does appear to be a limit on the level of E2F1 that CEF will tolerate. Overexpression of E2F1, using either an RCAS or RCASBP vector, induces morphological transformation of CEF. A closer examination of CEF infected with the BP-E2F1 virus showed that there was considerable apoptosis at the earliest passages following infection and that CEF expressing lower levels of E2F1 were selected. This is consistent with results from . However the remaining CEF still express substantial amounts of E2F1, and the cells are transformed even at late passages. Therefore, we do not believe that the failure of E2F1 to overcome p21 is a result of inadequate expression of E2F1. Instead, we favor the idea that it is an additional activity (or activities) of p21 that allows it to block the division of cells that overexpress E2F1. Recently, two distinct pathways for the transition from G 1 to S have been reported (Mann and Jones, 1996; Lukas et al., 1997) . Cyclin E/cdks, but not cyclin D/cdks, can drive cells into S phase by mechanisms that are distinct from E2F1 mediated transactivation (Lukas et al., 1997) . Cyclin D/cdks have been shown to be upstream of the pRb/E2F pathway (Mann and Jones, 1996) but cyclin E/cdks can drive cells to S phase independently of activating the pRb/E2F pathway (Lukas et al., 1997) . This implies targets for cyclin E/cdk which are downstream or on a parallel pathway to pRb/E2F and supports a role for p21 activity which is independent of E2F1.
In this system, E2F1 behaves similarly to Myc. Overexpression causes morphological transformation, and in addition, induces apoptosis. Perhaps this is not surprising since both of these proteins are transcriptional activators. E2F sites have been found in the promoter of c-myc (Hiebert et al., 1989) and a recent report (Leone et al., 1997) showed that E2F1 is a downstream target of c-Myc. In support of the view that there are similarities in the way in which these two transcription factors act, the apoptosis induced by overexpression of E2F1, like the apoptosis induced by overexpression of Myc, can be reversed by Bcl-2 overexpression. However, there are subtle dierences; v-Myc is a more potent inducer of apoptosis than c-Myc and drives cells into S phase in the presence of serum (Petropoulos et al., 1996) . Signi®cant apoptosis is seen seen in CEF expressing c-Myc only in the absence of serum. In this regard E2F1 behaves more like v-Myc that c-Myc. This distinction may be more arti®cial than real, however, since the induction of apoptosis by E2F1 in the presence of serum clearly depends on the level of E2F1 expression: considerably more apoptosis is seen when E2F1 is inserted in RCASBP than in RCAS. Both the level of E2F1 and the eect of Bcl-2 on the fate of cells that overexpress E2F1 (whether or not the cells will undergo apoptosis) may have implications for the ability of E2F1 to play a direct role in cellular transformation. In cells with relatively low levels of Bcl-2, modest overexpression of E2F1 will lead to apoptosis; cells with high level of Bcl-2 will be transformed by levels of E2F1 overexpression that would otherwise induce apoptosis.
Materials and methods
Construction and growth of RCASBP(A)E2F1 virus
The RCAS and RCASBP vectors have been described elsewhere (Hughes et al., 1987; Petropoulos and Hughes, 1991) . A 1.3 kb restriction fragment that contains the entire coding sequence for human E2F1 (Kaelin et al., 1992) was subcloned into the adaptor plasmid Puc-CLA112NCO. To facilitate cloning the human E2F1 sequences into the adaptor plasmid, PCR was used to create an NcoI site at the initiator ATG and to introduce a BamHI site after the TGA termination codon of the E2F1 cDNA. The PCR product was digested with NcoI and BamHI and the resulting fragment was cloned into the adaptor. The ends were con®rmed by sequencing and a major portion of the coding region was replaced with sequences from the original E2F1 clone (Kaelin et al., 1992) by exchanging a 1.238 kb StyI/XhoI fragment. This plasmid was digested with ClaI and the E2F1 containing fragment was cloned into RCAS(A) or RCASBP(A) to generate RCAS(A)E2F1 or RCASBP(A)E2F1. Ten mg of RCAS(A)E2F1 or RCASBP(A)E2F1 DNAs were transfected by the calcium phosphate method (Wigler et al., 1979; Hughes and Kosik, 1984) into CEF prepared from 13-day-old embryos of the EV-0 line. CEF cultures were generated and maintained as described elsewhere (Petropoulos and Hughes, 1991) .
Co-infection experiments
The Bcl-2 and p21 viruses have been described previously (Givol et al., 1994 (Givol et al., , 1995 . Ten mg of RCASBP(B)bcl-2 or RCASBP(B)p21 DNAs were transfected into CEF and viral stocks were collected after the cultures were completely infected (two or three cell passages). Five ml of fresh or frozen viral stocks were used to superinfect CEF transformed by E2F1. The cells were imaged using a Zeiss (Oberkochen, Germany) confocal laser scanning microscope (CLSM 410). Adobe Photoshop and Macromedia software were used to make a composite of these images. These were printed on a tektronics dye sublimation printer.
Western blotting (immunoblotting)
Infected cells were washed with PBS, scraped o the plate, collected by centrifugation and lysed in protein sample buer. Cell lysates were boiled and analysed by electrophoresis on a 12% polyacrylamide SDS gel, transferred to a nitrocellulose membrane (BA85; Schleicher & Schuell, Keene, NH) and reacted with a mouse anti-human E2F1 monoclonal antibody, KH95 (PharMingen, San Diego) and anti-human p21 monoclonal antibody Ab-1 (Oncogene Science, Cambridge MA). Protein bands were visualized by using an enhanced chemiluminescence (ECL) detection system (Amersham, Arlington Heights, IL).
Fluorescence-activated cell sorter (FACS) analysis
Non-adherent cells were collected by centrifugation of culture supernatants. Adherent cells were trypsinized and collected by centrifugation. Adherent and non-adherent cell fractions were pooled, ®xed, stained with propidium iodide and scanned as described previously (Givol et al., 1995) . Histograms were analysed using the Multiplus AV software (Phoenix Flow Systems, San Diego, CA).
BrdU pulse analysis and FACS analysis
Cells at 50% con¯uence were labeled for 1 h with 10 mM bromodeoxyuridine (BrdU). The cells were washed twice with PBS and returned to label-free media. At 0, 2, 4, 6, and 24 h after being labeled, the cells were harvested, ®xed, and stained with¯uorescein isothiocyanate conjugated anti-BrdU antibody (FLUOS, Bhoeringer Mannheim) as speci®ed by the manufacturer. The cells were then treated with RNase and propidium iodide as described previously (Givol et al., 1995) and analysed by bivariate¯ow cytometry on a Coulter EPICS Pro®le (Miami, Florida) measuring the BrdU-linked green¯uorescence (FITC) through a 525 nm bandpass ®lter and the DNA-linked red¯uorescence (PI) through a 610 nm wavelength ®lter. As a negative control, cells which were not labeled with p21 waf1/cip1 arrests growth of cells transformed by E2F1 I Givol et al BrdU were subjected to this procedure and used as a standard by which to gate the cytometer. Histograms were analysed using Multiplus AV software.
DNA fragmentation
Non-adherent cells from a culture of CEF infected with the BP-E2F1 virus were collected and DNA was extracted as described previously (Laird et al., 1991) . The DNA was analysed on a 2% agarose gel.
